Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 112 Show results per page	View Search Criteria \| Help With Results


1.		Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				40 to 90				Pharmaceutical / Industry				AVO108943 NCT00470834


2.		Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care, Treatment				Active				18 and over				Other				001-0015-211 NCT00127387


3.		Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				30 and over				Other				05-043 NCT00116142


4.		Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				Not specified				Other				05-007 NCT00142506


5.		Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Other				553 NCT00132301


6.		Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				No age specified				Other				05-8-4 NCT00243646

Last Modified: 10/8/2008 First Published: 1/25/2006


7.		Phase III Randomized Study of Androgen Suppression (AS) and Radiotherapy (RT) Versus AS and RT Followed by Docetaxel and Prednisone in Patients With Localized, High-Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				RTOG-0521 RTOG-0521, NCT00288080


8.		Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				20050147 NCT00286091

Last Modified: 10/8/2008 First Published: 5/11/2006


9.		Phase III Randomized Study of Zoledronate in Preventing Osteoporosis and Associated Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiotherapy and Luteinizing Hormone-Releasing Hormone Agonist Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				NCI				RTOG-0518 0518, RTOG-0518, NCT00329797

Last Modified: 7/30/2008 First Published: 6/9/2006


10.		Phase III Randomized Study of Pomegranate Extract in Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiotherapy for Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				ROLL-GUP-0205-1 UCLA-0507059-01, NCT00336934

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute